Aqtual
Latest round
- Series B
Last raised
- Jul 2025
Total raised
- $47M
Investors
- 5
About Aqtual
Based in California, US, and founded in 2018, Aqtual Inc. operates as a biotechnology research company that develops and manufactures precision medicine and equipment for the treatment and monitoring of cancers and chronic diseases. The company was founded by its CEO Diana Abdueva. In July 2025, Aqtual, Inc. The firm develops and produces precision drugs and devices for the monitoring and treatment of chronic conditions and cancers. It provides research and practical healthcare solutions and provides blood tests for disease detection, and monitoring. It offers healthcare solutions for inflammatory conditions, immunology, cardiovascular diseases, metabolic diseases, neurological conditions, etc.
Who invested in Aqtual
5 investors across 2 rounds
See all investors in Aqtual
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Aqtual
Who invested in Aqtual?
Aqtual has 5 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Aqtual raised?
Aqtual has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Aqtual last raise money?
Aqtual's most recent round on record is a Series B, in Jul 2025.
What does Aqtual do?
Based in California, US, and founded in 2018, Aqtual Inc.
Where is Aqtual headquartered?
Aqtual is headquartered in Hayward, US.
Which VCs invest in companies like Aqtual?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Aqtual's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Aqtual? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.